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Langerhans (LC) cells require incubation with protein anti-
gen for several days before the cells effectively stimulate 
proliferation of cloned, H-2 restricted, antigen-specific T h 
cells . In contrast, splenic antigen-presenting cells are immedi-
ately effective. LC are immediately competent, however, if 
an immunogenic peptide rather than the intact protein is the 
immunogen, indicating that resident or unchallenged LC 
have the required class II MHC and can provide the signals 
M ammalian epidermis contains a resident popula-tion of bone marrow-derived la + Langerhans cells (Le) . Presumably LC interact with antigens and process and present antigenic residues in the context of MHC class II to specific lymphocytes, 
but freshly isolated LC are completely or relatively ineffective in 
stimulating pro liferation of alloreactive lymphocytes [1 ,2] . In 
addition, as we report here, LC require several days incubation 
with protein antigen before they effectively stimulate prolifer-
ation of antigen specific T h 1 and T h2 cloned cells. We suggest 
this delayed capacity to process/present antigen is an intrinsic 
property of LC which may promote more efficient systemic 
in'lmunity. 
MATERIALS AND METHODS 
Mice C3H / H eN 5-6-week-old female mice purchased from an 
SPF colony (Frederick Cancer Research Center Animal Production 
Area) were housed in laminar fl ow hoods in the University of 
Chicago animal facility. Mice .v:ere given acidified water, and 
food and bedding were not stenlized. Mice were 8 weeks of age 
when used. 
Antigens and Reagents Fowl y-globulin (FGG) and na.tive Pi-
geon cytochrome c (Pe) were purchased from Sigma C hemical Co. 
(St . Louis, MO ). Key hole [nupct hemocya11ln (KLH) (Catalog No. 
374805) was purchased from Calbiochcmical (San Diego, CA) . 
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Abbreviations: 
aELR: autologous epidermal lymphocyte reaction 
AgELR: antigen-specific epidermal lymphocyte reaction 
EC: epidermal cell 
FGG: fowl yg lobulin 
KLH: keyhole limpet hemocyanin 
LC: Langerhans cell 
PC: native pigeon cytochrome c 
3 d LC: LC cultured for 3 d 
necessary for T -cell proliferation but may lack the capacity .to 
internalize or cleave protein antigens. W e propose that de-
layed antigen presentation by LC may be intrinsic and advan-
tageous for promoting early sys temic immunity. LC stimu-
late cloned T h 1 and T h2 cells equally well , suggesting that 
LC may not limit or bias the type of immunity that occurs 
with cutaneous antigenic challenge. ] Invest Dermato/ 
95:446-449, 1990 
The pigeon cytochrome c peptide fragnient containing the 
carboxyl terminal 81 to 104 amino acid residues (designated Pc 
81-104) purified fro m the C N Br cleavage of native pigeon cyro-
chrom.e c was a gift from Dr. Susan Pierce (Northwestern U niver-
sity). Trypsin XI (Catalog No. T1005) and Deoxyribo-
nuclease (Catalog No. 00876) were purchased from Sigma. Ami-
Thy 1 antibody (designated AT83A) is a rat monoclonal antibody, 
which was a generous gift of Dr. F. W . Fitch (University of 
C hicago). 
Culture Medium Epidermal cells and splenocytes were cul tured 
in a complete medium (CM) consisting of RPM I 1640 (Gibco Labo-
ratories, Grand Island, NY) supplemented with 2 mM L-glura-
mine, 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, 
5 X 10- 5 M mercaptoethanol, 10% FCS, 50 U penicillin and 50 f-l 
of streptomycin per 100 ml of medium. 
Preparation of Epidermal Cells (EC) The methods [3] for 
obtaining EC were a modification of the techniques learned in the 
laboratory of Dr. J. Nixon-Fulton. The pel ts and ears were soaked 
with 70% alcohol and the epidermis from th e ventral and dorsal 
halves of ears and strips of shaved truncal skin were incubated in a 
0.5% trypsin solution for 45' to free the epidermis fro m the under-
lying dermis. The epidermal sheet was further disaggregated into a 
single cell sllspension by gentle agitation for 30' in a solution of 
0.05% DNase. The resulting single cell suspension was filtered 
throu gh sterile Nitex mesh to remove hair and stratum corneum. 
Four to six X l 06 EC per pair of ears of greater than 85% viabil iry 
was routinely obtained. LC obtained from the low-density interface 
following Ficoll-Hypaque density gradient centri fugation (32% 
MHC IEH ) or LC obtained following furth er purification by re-
moving contaminating Thy-1 + kera tinocytes and y / 0 epidermal T 
cells by a combination of plas tic adherence for 1 h fo llowed br 
anti-Thy- l and RC mediated lysis (70% MHC IEH) were used as a 
source of fresh or day 1 LC. Four-day LC were obtained by bulk 
culturing EC at 2 X 107 cell s/ml in CM overnite in the presence or 
absence of antigen. The nonadhcrent EC were harvested and subse-
quently re-cultured for an additional 48 h in CM again in the pres-
ence or abse nce of antigen. Day-4 LC were obtained by harvesring 
the low-density interface band following Ficoll-hypaque densi ' 
gradient centrifugation (50% IEk+) . 
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Table I. MHC Restriction, Antigen Specificity, and Pattern of 
Lymphokine Secretion of T h Cell C lones 
T h Cell Clones MHC Restriction Antigen Specificity T h Class 
KC-1 IEk KLH T h1 
FGG.3 IEk FGG T h2 
PC-1S.8 IEk PC T h2 
LF2.2 IEk IEk T h2 
T h Cell Clones The MHC restriction, antigen specificity, a l~d 
pattern of Iymphokine secretion of the T h cell clones [4 ,5] gener-
ated in our laboratory are shown in Table I. 
The autoreactive, IEk reactive clone was stimulated weekly with 
fresh irJ:'adiated (2,000R) syngeneic C3H splenocytes. The antigen-
specific clones were maintained on a schedule of 7-d stimulation 
with anti gen (50 Jig/ml) and irradiated syngeneic spleen cells, fol-
lowed by 7-d rest with irradiated syngeneic spleen cells and no 
antigen. All clones were maintained in complete medium. 
Assessment of Antigen-Presenting Cell (APC) Function 
APC function was determined by using the epidermal mixed lym-
phocyte reaction (ELR). For the autologous ELR, the responder 
cloned T h cells were stimulated directly by th e IEk C3H APC; each 
autologous-ELR culture contained 2 X 104 IEk reactive T h cells 
and varying numbers of irradiated (2,000R) IEk bearing APC. In 
repeated titrations, the number ofLC required for optimal prolifera-
tion was 3 X 104 per culture; 105 LC per culture regularly caused 
10% lower responses. Simi larly, in preliminary experiments using 
graded doses ofWS, 5 X 105 cells were found to give optimal prolif-
eration. In initial experiments, using a wide range of antigen and 
peptide concentrations, we determined that optimum proliferation 
was induced by 10 JiM of Pc 81-104 and 50 Jig/ml of native pro-
rein antigens. IEk bearing APC included fresh ly isolated EC, fresh 
LC, 3-d cultured LC, fresh WS, and 3-d cultured WS, all irradiated 
2,000R. Both the autologous ELR and the :mti gen ELR were 
carried out in 96 well flat bottom tissue culture plates in a final 
volume of 200 Jil. In the antigen/ELR, the antigen varied depend-
ing on the specificity of the responder T h cell clone (i .e., in the 
FGG-ELR, the responders were FGG.3; in the KLH -ELR the res-
pondeJ:'s were KC-l; and in th e PC-ELR, the responders were 
PC15 .8) . Activation was measured by co-cultuJ:'ing antigen-pulsed 
IEk-bearing APC with 2 X 104 cloned T cells. Cultures were pulsed 
with 3H-thymidine on the third day and incorporation was mea-
sured 18 h later. 
RESULTS 
Fresh LC Cultured with Protein for 3 d Present Antigen As 
shown in T able II , fresh LC and protein antigen failed to stimulate 
Table II. Langerhans Cells Cultured with Protein for 3 d 
Present Antigen 
Day of Culture Response 
APC- KLH Addedb KC-1 Cells Added' Assay CPM±SDd 
LC 1 1 4 290 ± 35 
LC 1 4 7 14,871 ± 136 
LC 4 4 7 600 ± 79 
WS 1 1 4 30,052 ± 4,864 
WS 1 4 7 5,300 ± 489 
WS 4 4 7 1,1 11±145 
• APC were either 3 X 10' LC or 5 X 10' whole C3H splccn ce ll s; APC were irra-
di.ucd 2 ,OOOR. 
• KLH: 50 tlg/ ml added either On day I w hen cultu res were set up or after APe had 
been in c ulture for 3 d; i.e. on day 4. 
' 2 X 10' KC-l TH 1 cel ls. 
'Sening up of cultures was staggered so that all cultures were assayed on the same 
day. D ata arc mean C PM for three replicate cultures ± SD. 
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antigen-specific cloned T cells, whereas LC cultured for 3 d with 
the antigen before antigen-specific cloned T cells were added to 
cultures stimulated proliferation very strongly. In contrast, spleen 
cells were most effective when protein and cloned cells were added 
at the beginning of culture, possibly because after 3 d in culture 
MHC molecules were occupied by self-peptides or peptides derived 
from FCS. In other experiments, LC cultured with protein antigen 
for 2 to 4 d were variably effective but never more effective th an 
control LC incubated for 3 d (data not presented) . N either LC nor 
splee n cells stimulated if th e cell s were cultured first for 3 d before 
antigen and cloned T cells were added. The findings apply to two 
other antigen-specific clones as well (Table III). In addition to the 
four T h cell clones used for these experiments, we have obtained 
similar results with two additional clones of autoreactive T h 1 cells, 
another autoreactive T h2 clone, an antigen-reactive T h hybri-
doma, and a KLH-reactive T h 1 cell clone (data not shown). 
Thus, LC during 3 d of culture gain both the capacity to stimu-
late allospecific clones and to process/present. antigen. Further-
more, processing/presentation is antigen specific (Table IV) . 
Interestingly , LC that processed antigen during the 3 d, regard-
less of the antigen, no longer activated cells from the autoreactive 
clone LF2.2 (Table IV). Because cloned LF2.2 ce ll s presumably 
recognize IEk and a self-peptide or peptides derived from FCS, the 
failure of LC to stimulate LF2.2 cells after a 3-d culture with any 
one of the protei n antigens suggests that antigen fragments from 
these proteins may have displaced the pep tides recognized by LF2.2 
cells. It is possible that LC have a li.mited capacity to process mu lti-
ple antigens and/or have a slow or 11ITiited turnover of surface MHC 
molecul es . 
Fresh LC and LC Cultured for 3 d Present the Immuno-
dominant Determinant of a Prepared Protein Residue The 
well-characterized pigeon cytochrome c specific IEk-restricted anti-
gen system was used to differentiate antigen processing from anti-
gen presentation [6 - 8]. The immunodominant peptide (Pc 81-104) 
of native pigeon cytochrome c protein (PC) resides in the ca rboxyl 
terminal 81-104 amino acid residues of the intac t protein. Pc 81-
l04 is presented by conventional accessory cells without further 
processing when associated with an IEk molecul e. As shown in 
T able V, both fresh LC and 3-d LC " present" the immunodomin-
ant epitope Pc 81-104 to the cytochrome c reactive T h clone. Thus, 
fresh LC have the required class II MH C molecules and can provide 
the necessary signals for T-cell prol iferation. Presumabl y, fresh LC 
lack the capability to internalize and/or cleave protein to peptides 
that complex with MHC. It is unlikely that the procedure for isolat-
ing LC causes this incapacity, because in repeated experiments we 
found that spleen cells prepared identically to LC using trypsin and 
DNase were as effective as conventionally prepared spleen cells for 
stimulating the panel of clones tested here from day 1. 
DISCUSSION 
Several laboratories have investigated th e antigen-presenting func-
tions ofLC and have reported conflicting results. In agreement with 
our findings, Picut et al [9] and Shimada et al [lOJ have shown that 
cultured LC ex hibit enhanced antigen-presentin g properties. In 
contras t, Romani et al [11 J concluded that intact protein is presented 
best by immature LC, whereas Streil ein and Grammer observed that 
fresh LC ca n process protein antigens with great effi ciency [1 2]. In 
the experiments reported by Romani et al it was noted that cultured 
LC were more active as MLR stimulators than fres hly isolated cells, 
a finding previously reported by Picut and confirmed by us (unpub-
lished results). Thus there is agreement on the relative abil ities of 
fresh and cultured LC in terms of alloantigenic prese ntation. 
Romani et al also reported that both fresh and cultured LC 
presented peptide fragments to a myoglobin specific clone with 
equivalent effici ency, a findin g reproduced by our observa tions us-
ing the Pc peptide (Table V). In contrast to our observations with 
FGG and KLH protein anti gens, these authors found that fresh LC 
ce lls presented myoglobin better than cultured cells. It is possible 
that the results simply reflect the differences in th e kinetics of pro-
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Table III. Comparison of Fresh Langerhans Cells and Langerhans Cells Cultured for 3 d' 
Day of Culture 
Clone Protein APC Antigen Added 
KLH LC 1 
KC-1 KLH LC 4 
KLH WS 
PC LC 1 
PC1S.8 PC LC 4 
PC WS 1 
FGG LC 1 
FGG.3 FGG LC 4 
FGG WS 1 
" Conditions were the same as in Table II. 




Clone Antigen CPM±SD CPM±SD 
None 245 ± 21 272± 34 
KLH 15,578 ± 136 38,518 ± 774 
KC-l PC 274 ± 29 258 ± 83 
FGG 283 ± 10 223 ± 47 
None 349 ± 15 319 ± 51 
KLH 296 ± 32 288 ± 21 
PC15.8 PC 44 ,266 ± 4,191 92,919 ± 419 
FGG 354 ± 51 376 J: 37 
None 289 ± 21 233 ± 47 
KLH 187 ± 95 342 ± 13 
FGG.3 PC 269 ± 37 215 ± 92 
FGG 45,645 ± 2,063 36,590 ± 322 
None 183,242 ± 6,371 82,121 ± 892 
LF2.2 KLH 272 ± 33 53,314 ± 613 
PC 129 ± 59 NO 
FGG 255 ± 30 71,605 ± 306 
• Conditions were the same as in Table ll, i. e. , all LC were cultured with antigen for 3 
d before cloned cells were added to cultures. WS, antigen and cloned cells were cultured 
together from day 1. 
cessing for FGG , KLH, and myoglobin by LC. Another factor con-
tributing to the loss of ability of cultured LC ceJls to present myoglo-
bin is likely to be the displacement of the relevant antigenic frag-
ment from the MHC groove by peptide fragments generated in 
culture. This form of antigenic competition at the level of the anti-
Table v. Either Fresh or Cultured Langerhans Cells Present 
Peptide 
Day of Culture 
Peptide PC1 5.8 Response 
APC Peptide" Added CelJs Added Assay (CPM± SOb) 
LC + 1 1 4 25,391 ± 231 
LC + 4 4 7 58,324 ± 1,769 
LC None 1 4 334 ± 41 
None + 4 4 7 318 ± 60 
WS + 1 1 4 75,001 ± 4,102 
II Pc 8 1-104 , the immullodominant peptide of pigeon cytochrome c. was added at a 
final concentration of 10 JjM. 
b Conditiolls the same as for T able II . 
Cloned Cells Added Assay Response (CPM ± SD) 
4 7 15,578 ± 136 
4 7 378 ± 40 
4 38,518 ± 774 
4 7 64,822 ± 4,572 
4 7 1,212±130 
1 4 34,953 ± 3,490 
4 7 53,466 ± 5,736 
4 7 8,225 ± 375 
1 4 46,696 ± 3,233 
gen-presenting MHC molecule probably accounts for the loss 0 
reactivity ofLF.2 cells to syngeneic LC cultured with the irrelevant 
proteins KLH, PC, and FGG (Table IV) . One might expect that 
unrelated anti genic fragments compete differently with peptide'S 
generated in culture. In addition, the outcome of this competition 
will be different for LC vs splenic APC because these cells can 
generate different types of self-derived pep tides. 
The findings of Streilein and Grammer only differ from ours 
partially. In agreement with the findings of Romani and those re-
ported here, Streilein and Grammer also observed that fresh an 
cultured LC presented peptide fragments equally well. The discrep-
ancies between our results and those of Streilein and Grammer 
pertain exclusively to their observations on IL2 production by T-
cell hybridomas stimulated with OVA pulsed LC. Their results 
using proliferation of antigen primed T cell s agree with ours, and 
we attribute the variant findings with the hybridomas to differential 
kinetics of antigen processing and presentation as discussed above. 
Delayed antigen presentation by LC may be intrinsic and advan-
tageous for promoting early systemic immunity. Systemic immu. 
nity depends on recruitment of recirculating antigen-specific Iym. 
phocytes to regional nodes or spleen [13,14] by antigen-presentin 
cells that have interacted with antigen. A delay in antigen presenta-
tion by LC may provide time for LC that have interacted "ith 
antigen to migrate to lymphatic tissue where recruitment/activa-
tion of lymphocytes is more efficient. More importantly, the delay 
may allow resident an tigen-presenting cells in lymphatic tissue co 
interact with free or phagocytized antigen transported to this tissue 
early to begin recruitment/activation oflymphocytes immediately. 
With sustained or subsequent cutaneous antigen challenge, L 
presenting specific peptide/class II complexes may be targets and! 
or stimulus for specific lymphocytes activated centrally. In addition, 
with sustained or subsequent cutaneous antigenic challenge. KC 
may be stimulated to produce cytokines (e.g .• GMCSF, which, at 
least in vitro, causes LC to stimulate more effectively) or earlier 
alloreactive lymphocytes [15J. Extrapolating from our results usin<> 
cloned antig.en specific T cells, it would appear that LC that haw 
interacted with antigen for several days stimulate equally well-acti-
vated T h 1 and T h2lymphocytes; i.e., LC may not limit or bias th~ 
type of immunity that occurs with cutaneous antigenic challenge. 
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CONFERENCE ON MOLECULAR AND STRUCTURAL BIOLOGY 
OF HAIR GROWTH 
A Conference on Molecular and Structural Biology of Hair Growth will be held at the Crystal 
Gateway Marriot, Arlington, VA, ]anuary 23-25,1991, sponsored by The New York Acad-
emy of Sciences. 
Information will be exchanged during this meeting which will use the formats of formal 
lectures, open discussions, posters, and social gatherings. The major topics discussed will in-
clude: the regulation of hair follicle structural protein expression, the themes of the molecular 
structure of hair, laboratory models for studying hair growth, the mesenchymal components of 
the follicle, hair follicle pigmentation, growth factors and cytokines affecting hair growth, 
hormonal influence on molecular processes of the follicle, and principles of hair follicle induc-
tion and cycle. 
The phenomenon of mammalian cutaneous hair growth serves as a model system for study-
ing the basic biological problems of differentiation and epithelial-mesenchymal interactions. 
The recent application of tools of modern cellular and molecular biology to this system 
prompted the interest in an international meeting of hair biology investigators. Conference 
Chairmen: Dr. K. S. Stenn, Yale University, 333 Cedar Street, New Haven, CT 06510-8058; 
A. G. Messenger, Dept. of Dermatology, Royal Hallamshire Hospital, University of Sheffield, 
Sheffield, England; Howard P. Baden, Department of Dermatology, Massachusetts General 
Hospital, Fruit Street, Boston, MA 02114. 
